Concepedia

Paul R. Hinton

PR

8

Publications

915

Citations

8

H-Index

1999

Active since

Affiliations

PDL BioPharma (United States)(Current)

IGM Biosciences (United States)

Paul R. Hinton is an author at PDL BioPharma (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1999–2021

8

Publications

8

An Engineered Human IgG1 Antibody with Longer Serum Half-Life

Paul R. Hinton, Joanna M. Xiong, Mary G. Johlfs et al. · The Journal of Immunology · 2006 · 279 citations · Full text

, , +17

Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates

Paul R. Hinton, Mary G. Johlfs, Joanna M. Xiong et al. · Journal of Biological Chemistry · 2004 · 271 citations · Full text

Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants

Zhiqiang Ku, Xuping Xie, Paul R. Hinton et al. · Nature · 2021 · 182 citations · Full text

, , +7

Design of humanized antibodies: From anti-Tac to Zenapax

Naoya Tsurushita, Paul R. Hinton, Shankar Kumar · Methods · 2005 · 87 citations

, , +4

Amphiregulin and Epidermal Hyperplasia

Narasimharao Bhagavathula, Kamalakar C. Nerusu, Gary J. Fisher et al. · American Journal Of Pathology · 2005 · 52 citations · Full text

, , +6

Rows per page

1–5 of 8